Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexins role in neurodegenerative diseases: From pathogenesis to treatment
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 22

Showing 22 citing articles:

Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 24
Achieving brain clearance and preventing neurodegenerative diseases—A glymphatic perspective
Tekla Maria Kylkilahti, Eline Berends, Marta Ramos, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 9, pp. 2137-2149
Open Access | Times Cited: 48
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 21
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 17
Orexin-A alleviates ferroptosis by activating the Nrf2/HO-1 signaling pathway in traumatic brain injury
Junwei Kang, Bingkai Ren, Lianghua Huang, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 3404-3419
Open Access | Times Cited: 7
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
On the relationships between epilepsy, sleep, and Alzheimer’s disease: A narrative review
Julie M. Hanke, Kaspar Schindler, Andrea Seiler
Epilepsy & Behavior (2022) Vol. 129, pp. 108609-108609
Open Access | Times Cited: 20
Parkinson’s Disease: Biomarkers for Diagnosis and Disease Progression
Rakesh Arya, A. K. M. Ariful Haque, Hemlata Shakya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12379-12379
Open Access | Times Cited: 4
Computational Analysis of the Fully Activated Orexin Receptor 2 across Various Thermodynamic Ensembles with Surface Tension Monitoring and Markov State Modeling
Rafael Doležal
The Journal of Physical Chemistry B (2025)
Closed Access
Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 44, pp. 7582-7596
Open Access | Times Cited: 16
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau, Nicole Pascal, Gratio Valérie, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4849-4849
Open Access | Times Cited: 15
Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson’s disease patients
Shen Huang, Zhenxiang Zhao, Jianjun Ma, et al.
Neuroscience Letters (2020) Vol. 741, pp. 135480-135480
Closed Access | Times Cited: 16
Computational Analysis of Fully Activated Orexin Receptor 2 Across Various Thermodynamic Ensembles with Surface Tension Monitoring
Rafael Doležal
(2024)
Open Access | Times Cited: 1
Dual Orexin Receptor Antagonists as Promising Therapeutics for Alzheimer’s Disease
Sydney M. Ragsdale, Jenna Radovich, Isabel I. Coiduras, et al.
(2024)
Open Access | Times Cited: 1
Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder
Yuan Yuan, Yimeng Zhang, Yueyang Cheng, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 5
Imaging flow cytometry of tumoroids: A new method for studying GPCR expression
Valérie Gratio, Stéphanie Dayot, Samira Benadda, et al.
Cytometry Part A (2023) Vol. 105, Iss. 4, pp. 276-287
Open Access | Times Cited: 2
Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives
Anna Costagliola, Renato Lombardi, Giovanna Liguori, et al.
Cancer Genomics & Proteomics (2023) Vol. 20, Iss. 6suppl, pp. 637-645
Open Access | Times Cited: 2
The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer’s Disease
Miklós Jászberényi, Balázs Thurzó, Arumugam R. Jayakumar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13086-13086
Open Access
In vivo microdialysis reveals that blockade of accumbal orexin OX2 but not OX1 receptors enhances dopamine efflux in the nucleus accumbens of freely moving rats
Hiroki Kawashima, Yuri Aono, Yuriko Watanabe, et al.
European Journal of Neuroscience (2022) Vol. 55, Iss. 3, pp. 733-745
Closed Access | Times Cited: 2
Synthesis and Characterization of Novel Radioiodinated Triazole-Pyrolidine Derivative to Detect Orexin 2 Receptor in the Brain
Hiroyuki Watanabe, Takuji Ide, Masahiro Ono
Chemical and Pharmaceutical Bulletin (2023) Vol. 71, Iss. 3, pp. 234-239
Open Access
Page 1

Scroll to top